These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer. Kim EK; Kim KA; Lee CY; Kim S; Chang S; Cho BC; Shim HS Clin Lung Cancer; 2019 Jan; 20(1):e123-e132. PubMed ID: 30391211 [TBL] [Abstract][Full Text] [Related]
23. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Mosele F; Remon J; Mateo J; Westphalen CB; Barlesi F; Lolkema MP; Normanno N; Scarpa A; Robson M; Meric-Bernstam F; Wagle N; Stenzinger A; Bonastre J; Bayle A; Michiels S; Bièche I; Rouleau E; Jezdic S; Douillard JY; Reis-Filho JS; Dienstmann R; André F Ann Oncol; 2020 Nov; 31(11):1491-1505. PubMed ID: 32853681 [TBL] [Abstract][Full Text] [Related]
27. Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing. Cohen D; Hondelink LM; Solleveld-Westerink N; Uljee SM; Ruano D; Cleton-Jansen AM; von der Thüsen JH; Ramai SRS; Postmus PE; Graadt van Roggen JF; Hoppe BPC; Clahsen PC; Maas KW; Ahsmann EJM; Ten Heuvel A; Smedts F; van Rossem RN; van Wezel T J Thorac Oncol; 2020 Jun; 15(6):1000-1014. PubMed ID: 32014610 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization. Ali SM; Hensing T; Schrock AB; Allen J; Sanford E; Gowen K; Kulkarni A; He J; Suh JH; Lipson D; Elvin JA; Yelensky R; Chalmers Z; Chmielecki J; Peled N; Klempner SJ; Firozvi K; Frampton GM; Molina JR; Menon S; Brahmer JR; MacMahon H; Nowak J; Ou SH; Zauderer M; Ladanyi M; Zakowski M; Fischbach N; Ross JS; Stephens PJ; Miller VA; Wakelee H; Ganesan S; Salgia R Oncologist; 2016 Jun; 21(6):762-70. PubMed ID: 27245569 [TBL] [Abstract][Full Text] [Related]
29. Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival. Al-Ahmadi A; Ardeshir-Larijani F; Fu P; Cao S; Lipka MB; Dowlati A; Bruno DS Clin Lung Cancer; 2021 Jan; 22(1):16-22.e1. PubMed ID: 33397584 [TBL] [Abstract][Full Text] [Related]
30. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer. Ju S; Cui Z; Hong Y; Wang X; Mu W; Xie Z; Zeng X; Su L; Lin X; Zhang Z; Zhang Q; Song X; You S; Chen R; Chen W; Xu C; Zhao J Cancer; 2023 Aug; 129(15):2422-2430. PubMed ID: 37096747 [TBL] [Abstract][Full Text] [Related]
31. A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population. Heredia D; Mas L; Cardona AF; Oyervides V; Motta Guerrero R; Galvez-Nino M; Lara-Mejía L; Aliaga-Macha C; Carracedo C; Varela-Santoyo E; Ramos-Ramírez M; Davila-Dupont D; Martínez J; Cruz-Rico G; Remon J; Arrieta O Lung Cancer; 2022 Dec; 174():133-140. PubMed ID: 36379126 [TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of genomic profiles between tissue-based and plasma-based next-generation sequencing in patients with non-small cell lung cancer. Lin Z; Li Y; Tang S; Deng Q; Jiang J; Zhou C Lung Cancer; 2023 Aug; 182():107282. PubMed ID: 37392713 [TBL] [Abstract][Full Text] [Related]
33. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms]. Li Y; Zhang FS; Guo L; Ying JM Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169 [No Abstract] [Full Text] [Related]
34. Real-World Clinical Outcomes after Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer. Olsen S; Liao J; Hayashi H Curr Oncol; 2022 Jul; 29(7):4811-4826. PubMed ID: 35877242 [TBL] [Abstract][Full Text] [Related]
35. Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients. Xi Y; Bai Z; Gao S; Guo J; Zhang Z; Zhang H; Qu L; Xu B; Wang W; Shan G; Cui W; Bai W; Ji X J Cancer Res Clin Oncol; 2023 Sep; 149(11):8573-8580. PubMed ID: 37186065 [TBL] [Abstract][Full Text] [Related]
36. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics. Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211 [TBL] [Abstract][Full Text] [Related]
37. Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer. Shi Y; Lei Y; Liu L; Zhang S; Wang W; Zhao J; Zhao S; Dong X; Yao M; Wang K; Zhou Q Cancer Med; 2021 Apr; 10(7):2216-2231. PubMed ID: 33655698 [TBL] [Abstract][Full Text] [Related]
38. Developing an effective quality evaluation strategy of next-generation sequencing for accurate detecting non-small cell lung cancer samples with variable characteristics: a real-world clinical practice. Rao W; Guo L; Ling Y; Dong L; Li W; Ying J; Li W J Cancer Res Clin Oncol; 2023 Jul; 149(8):4889-4897. PubMed ID: 36305947 [TBL] [Abstract][Full Text] [Related]
39. Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer. Zhao S; Zhang Z; Zhan J; Zhao X; Chen X; Xiao L; Wu K; Ma Y; Li M; Yang Y; Fang W; Zhao H; Zhang L BMC Med; 2021 Oct; 19(1):223. PubMed ID: 34592968 [TBL] [Abstract][Full Text] [Related]
40. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients. Descarpentries C; Leprêtre F; Escande F; Kherrouche Z; Figeac M; Sebda S; Baldacci S; Grégoire V; Jamme P; Copin MC; Tulasne D; Cortot AB J Thorac Oncol; 2018 Dec; 13(12):1873-1883. PubMed ID: 30195702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]